MSB is certainly not for the faint-hearted. Which is ironic because our key product for heart (which may be needed for some of us LTH’s) is showing the most promise.
I think these results and the datasets have taken everyone by surprise. It has always been about the science and we have confirmation that it works and has the ability to save thousands of lives.
Well done if you’ve held your nerve over the last month and not sold out. If you haven’t then it may be time to get back in, however DYOR.
GLTAH
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF, page-317
-
- There are more pages in this discussion • 447 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.51 |
Change
0.020(1.34%) |
Mkt cap ! $1.724B | |||
| Open | High | Low | Value | Volume |
| $1.57 | $1.58 | $1.41 | $18.15M | 12.09M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3418 | $1.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.51 | 24361 | 5 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |